A long-term surviving patient with recurrent low-grade serous ovarian carcinoma treated with the MEK1/2 inhibitor, selumetinib
Takekuma, Munetaka, Wong, Kwong K., Coleman, Robert L.Volume:
3
Language:
english
Journal:
Gynecologic Oncology Research and Practice
DOI:
10.1186/s40661-016-0026-5
Date:
December, 2016
File:
PDF, 675 KB
english, 2016